Iradimed gets MRI infusion pump back on the market

Iradimed's stock shoots up nearly 15% on news that it can return to market with MRI-friendly intravenous infusion pump systems, which were pulled after an FDA inspection.

Food & Drug Administration (FDA), Iradimed Corp

News Well, 510(k), Drug Pumps, Imaging, Regulatory/Compliance, Warning Letter

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JJ8HWo